CCM
NVO

Cinctive Capital Management’s Novo Nordisk NVO Stock Holding History

Cinctive Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,154
Closed -$1.18M – 474
2025
Q4 		$1.18M Buy
+23,154
New +$1.18M 0.06% 264
2025
Q1 		– Sell
-6,678
Closed -$574K – 420
2024
Q4 		$574K Buy
+6,678
New +$722K 0.03% 312
2021
Q4 		– Sell
-29,140
Closed -$1.4M – 622
2021
Q3 		$1.4M Buy
+29,140
New +$1.41M 0.07% 354

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Cinctive Capital Management's NVO Position: Q1 2026 in Review

Cinctive Capital Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 23,154 shares — an estimated $1.18M sold.

Cinctive Capital Management first reported a position in NVO in Q3 2021 and held it in 3 quarters. The position peaked at $1.4M in Q3 2021. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Cinctive Capital Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 23,154 Novo Nordisk shares in Q1 2026, an estimated $1.18M.
  • Cinctive Capital Management first reported a position in Novo Nordisk in Q3 2021 and held it in 3 quarters.
  • Cinctive Capital Management's Novo Nordisk position peaked at $1.4M in Q3 2021.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.